Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Institut de Cancérologie de Bourgogne (ICB) is a prominent private oncology group based in the Burgundy region of France, specializing in comprehensive cancer treatment and clinical research. The institute provides advanced radiotherapy services, including Intensity-Modulated Radiation Therapy (IMRT), Volumetric Modulated Arc Therapy (VMAT), and stereotactic radiotherapy, alongside medical oncology treatments such as chemotherapy and immunotherapy. Operating across multiple facilities in Dijon, Chalon-sur-Saône, Auxerre, and Sens, ICB serves as a regional hub for oncological expertise. The organization is also heavily involved in clinical research, maintaining a dedicated department that participates in numerous international Phase II and Phase III clinical trials to offer patients access to cutting-edge therapeutic innovations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Institut de Cancérologie de Bourgogne.